A detailed history of Bouvel Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bouvel Investment Partners, LLC holds 6,501 shares of LLY stock, worth $5.51 Million. This represents 2.33% of its overall portfolio holdings.

Number of Shares
6,501
Previous 6,501 -0.0%
Holding current value
$5.51 Million
Previous $5.89 Million 2.14%
% of portfolio
2.33%
Previous 2.46%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $30,444 - $38,179
42 Added 0.65%
6,501 $5.89 Million
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $1.37 Million - $1.83 Million
2,313 Added 55.79%
6,459 $5.02 Million
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $99,260 - $117,015
189 Added 4.78%
4,146 $2.42 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $1.72 Million - $2.37 Million
3,957 New
3,957 $2.13 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bouvel Investment Partners, LLC Portfolio

Follow Bouvel Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bouvel Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bouvel Investment Partners, LLC with notifications on news.